動物用ワクチンの世界市場：家畜用ワクチン、コンパニオン動物用ワクチン、家禽用ワクチン、馬用ワクチン、豚用ワクチン...市場調査レポートについてご紹介

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 22)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions for the Study

3 Executive Summary (Page No. – 30)

4 Premium Insights (Page No. – 37)
4.1 Veterinary Vaccines Market to Grow at A Steady Rate
4.2 Veterinary Vaccines Market, By Product
4.1 Veterinary Vaccines Market, By Region
4.2 Veterinary Vaccines Market, By Technology
4.3 Lifecycle Analysis, By Region

5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Diseases in Animals
5.2.1.2 Increasing Incidence of Zoonotic Diseases
5.2.1.3 Increasing Investments By Various Government Agencies, Animal Associations, and Leading Players
5.2.1.4 Introduction of New Types of Vaccines
5.2.2 Restraints
5.2.2.1 Rising Maintenance Costs for Storage of Vaccines
5.2.2.2 Increasing Adoption of Vegetarian Food Across Major Economies
5.2.3 Opportunities
5.2.3.1 Technological Innovations Such as DNA Vaccines
5.2.3.2 Growing Awareness of Animal Health in Emerging Economies

6 Veterinary Vaccines Market, By Product (Page No. – 47)
6.1 Introduction

7 Veterinary Vaccines Market, By Disease (Page No. – 50)
7.1 Introduction
7.2 Porcine Vaccines, By Disease
7.3 Porcine Diseases: Overview
7.4 Poultry Vaccines, By Disease
7.5 Poultry Diseases: Overview
7.6 Companion Animal Vaccines, By Disease
7.7 Canine Vaccines
7.8 Canine Diseases: Overview
7.9 Feline Vaccines
7.10 Feline Diseases: Overview
7.11 Livestock Vaccines, By Disease
7.11.1 Bovine Vaccines
7.12 Bovine Diseases: Overview
7.12.1 Small Ruminant Vaccines, By Disease
7.13 Samll Ruminant Diseases: Overview
7.14 Equine Vaccines, By Disease
7.15 Equine Diseases: Overview
7.16 Aquaculture Vaccines, By Disease
7.17 Aquaculture Diseases: Overview

8 Veterinary Vaccines Market, By Technology (Page No. – 68)
8.1 Introduction
8.2 Live Attenuated Vaccines (LAV)
8.3 Inactivated Vaccines
8.4 Toxoid Vaccines
8.5 Recombinant Vaccines
8.6 Conjugate Vaccines
8.7 Subunit Vaccines
8.8 DNA Vaccines

9 Veterinary Vaccines Market, By Region (Page No. – 81)
9.1Introduction
9.2 Europe
9.3 North America
9.4 Asia
9.5 China
9.5.1 Thailand
9.5.1.1 Regulatory Landscape for Veterinary Vaccines in Thailand
9.6 India
9.7 Rest of the World (RoW)
9.8 Brazil

10 Competitive Landscape (Page No. – 157)
10.1 Overview
10.2 Market Share Analysis
10.3 Veterinary Vaccines Market, Major Developments, By Product (2013–2015)
10.3.1 Recent Developments By Market Players (2013–2015)
10.3.1.1 Zoetis (Pfizer)
10.3.1.2 Merck Animal Health
10.3.1.3 Boehringer Ingelheim
10.3.1.4 Ceva Animal Health
10.4 Competitive Situation and Trends
10.4.1 New Product Launches
10.4.2 Agreements, Partnerships, and Collaborations
10.4.3 Acquisitions
10.4.4 Expansion
10.4.5 Other Developments

11 Company Profiles (Page No. – 168)
11.1 1.1 Introduction
11.2 Bayer Healthcare
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Recent Developments
11.3 Bioniche Animal Health
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Recent Developments
11.4.4 MnM View
11.5 Ceva Animal Health
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Recent Developments
11.6 Elanco Animal Health (Eli Lilly)
11.6.1 Business Overview
11.6.2 Product Portfolio
11.6.3 Recent Developments
11.6.4 MnM View
11.7 Heska Corporation
11.7.1 Business Overview
11.7.2 Product Portfolio
11.7.3 Recent Developments
11.8 Merck Animal Healthcare
11.8.1 Business Overview
11.8.2 Product Portfolio
11.8.3 Recent Developments
11.8.4 MnM View
11.9 Merial Inc. (SANOFI)
11.9.1 Business Overview
11.9.2 Product Portfolio
11.9.3 Recent Developments
11.9.4 MnM View
11.10 Virbac
11.10.1 Business Overview
11.10.2 Product Portfolio
11.10.3 Recent Developments
11.11 Zoetis
11.11.1 Business Overview
11.11.2 Product Portfolio
11.11.3 Recent Developments
11.11.4 MnM View

12 Appendix (Page No. – 193)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports